What R97 covers · when clinicians use it
ICD-10 code R97 identifies Abnormal tumor markers in the U.S. ICD-10-CM clinical and billing record set. It sits within the Symptoms, Signs & Abnormal Findings chapter (R00–R99), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply R97 when an encounter's findings match the Abnormal tumor markers description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify R97 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for R97 and is a coding reference, not clinical, diagnostic, or billing advice.
ICD10 code R97 is used for Abnormal tumor markers, helping healthcare providers document cases where either tumor markers suggest malignancy or mortality causes remain unclear at the time of coding.
Symptoms
- Elevated AFP, CEA, CA-125, or PSA markers – R97
- Unexplained sudden death – R99
- No clear pathology found on postmortem – R99
- Unexpected tumor marker elevation without clinical cancer diagnosis – R97
- Death certificates listing cause as "unknown" – R99
Diagnosis
Abnormal tumor markers are identified through blood tests used for screening, diagnosis, or monitoring malignancies. Unknown mortality causes are coded when death investigations remain inconclusive after autopsy or clinical assessment.
ICD10 Code Usage
R97 is crucial in situations where full diagnostic clarity is unavailable but preliminary findings or outcomes still need formal medical recording for clinical, legal, and research purposes.
Related Codes
FAQs
Q1: What is ICD10 code R97?
A: It refers to either the presence of abnormal tumor markers or deaths where no definitive cause can be assigned.
Q2: Are tumor markers diagnostic of cancer?
A: No, they are indicators that require confirmation through biopsy, imaging, and other diagnostic evaluations.
Q3: When is R99 used officially?
A: When the cause of death remains undetermined despite reasonable efforts like autopsies or forensic investigations.
Q4: Can R97 lead to early cancer detection?
A: Yes, abnormal tumor markers sometimes prompt early diagnosis of hidden malignancies.
Q5: How are these codes important for healthcare data?
A: They allow public health monitoring of unexplained deaths and potential cancer trends, improving healthcare system responses.
Conclusion
ICD10 code R97 ensures important clinical abnormalities and uncertainties are documented, supporting better future diagnosis, research, epidemiology, and healthcare resource planning.